Linden Advisors’s Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$7K 687
2022
Q3
$7K Hold
100,000
﹤0.01% 670
2022
Q2
$29K Hold
100,000
﹤0.01% 631
2022
Q1
$48K Buy
+100,000
New +$76.5K ﹤0.01% 665

Other funds holding WPCA.WS

Linden Advisors's WPCA.WS Position: Q4 2022 in Review

Linden Advisors sold out of Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCA.WS) in Q4 2022, closing a stake of 100,000 shares — an estimated $7K sold.

Linden Advisors first reported a position in WPCA.WS in Q1 2022 and held it in 3 quarters. The position peaked at $48K in Q1 2022. 5 funds tracked by Wall St. Rank hold WPCA.WS as of Q4 2022.

  • Linden Advisors reported no remaining Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Linden Advisors sold 100,000 Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $7K.
  • Linden Advisors first reported a position in Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • Linden Advisors's Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $48K in Q1 2022.
  • 5 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.